Ambrosia Bio To Use Ginkgo Enzyme Services To 'develop an expression strain for the scalable production of the Ambrosia Bio proprietary enzymes used for the conversion of feedstock into allulose'
Portfolio Pulse from Benzinga Newsdesk
Ambrosia Bio has partnered with Ginkgo Bioworks to develop an expression strain for the scalable production of Ambrosia Bio's proprietary enzymes. These enzymes are used for the conversion of feedstock into allulose.
June 29, 2023 | 11:10 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ginkgo Bioworks, which trades under the ticker DNA, is partnering with Ambrosia Bio to develop a scalable production process for Ambrosia's proprietary enzymes.
The partnership with Ambrosia Bio could lead to increased business for Ginkgo Bioworks, potentially leading to increased revenues and a positive impact on the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80